<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15870">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02900287</url>
  </required_header>
  <id_info>
    <org_study_id>2014/CHU/05</org_study_id>
    <nct_id>NCT02900287</nct_id>
  </id_info>
  <brief_title>Cancer Survival in Reunion Island , 1998-2008 (SUCRE)</brief_title>
  <acronym>SUCRE</acronym>
  <official_title>Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de la Réunion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de la Réunion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer survival is important to determine prognostic of patients and evaluate care and
      prevention health strategies. Sucre is the first study to describe cancer survival in
      Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by
      cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between
      01/01/1998 and 31/12/2008.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data are extracted from Reunion Island Cancer Registry.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>5 years related survival rate by cancer site and gender</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1, 3, 5 and 10 years related survival rate by cancer site and gender</measure>
    <time_frame>1, 3, 5 and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1, 3, 5 and 10 years standardised survival rate by cancer site and gender</measure>
    <time_frame>1, 3, 5 and 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1, 3, 5 and 10 years related survival rate by age at diagnosis</measure>
    <time_frame>1, 3, 5 and 10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">18000</enrollment>
  <condition>Neoplasms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Study population extracted from Reunion Island Cancer Registry
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients domiciled in Reunion Island at diagnosis

          -  Patients with at least 15 years of age at diagnosis

          -  Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

        Exclusion Criteria:

          -  Cutaneous malignant cancer expected melanoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 13, 2016</lastchanged_date>
  <firstreceived_date>September 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Survival</keyword>
  <keyword>Cancer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
